Literature DB >> 26202295

Lean NASH: distinctiveness and clinical implication.

Kausik Das1, Abhijit Chowdhury2.   

Abstract

INTRODUCTION: Non-alcoholic fatty liver (NAFL) in the absence of overweight and/or obesity, defined by the anthropometric parameter, body mass index (BMI), has been designated as 'lean NASH.' While maintaining a close pathophysiological link with metabolic syndrome (MS) and insulin resistance (IR), the presence of subtle alterations in measures of total body and regional adiposity not exceeding the designed cut-offs, are hallmarks of 'lean NASH.'
MATERIAL AND METHODS: Available literature related to non-alcoholic steatohepatitis (NASH) in lean or non-obese individuals and its pathogenesis in general published in English language journals till the time of manuscript preparation were reviewed and critically analysed. ANALYSIS: Being a closely related but variant phenotype of NASH, its features metabolically resemble the well-characterized entity 'metabolically obese normal weight (MONW)' individuals. Apart from total body adiposity, distribution of fat in different body compartments has assumed greater pathophysiologic relevance in characterizing 'lean NASH'. Detection of NASH in stringently defined non-obese individuals, by both BMI and waist circumference indices, indicates existence of a subset of NASH in which fat compartmentalization at ectopic sites is not picked up by the anthropometric yardsticks used. Volume [Quantity] and biological behavior of the visceral and deep subcutaneous adipose tissues contribute to this variant of NASH in non-obese subjects. Genetic predisposition to IR and MS along with the environmental influences like childhood nutritional status, dietary composition and gut microbiome possibly play pathogenetic role.
CONCLUSION: The most important concern is in the principles of nomenclature within syndromes where clinical dissimilarities exist despite biological similarities. Till a uniformly acceptable pathophysiological and/or etiology-based classification emerges, the term "lean NASH" would continue to provide us an opportunity to ponder over and refine this subset of fatty liver in non-obese people and potentially significant liver disease.

Entities:  

Keywords:  Adiposity; BMI; Lean; Obesity; Steatohepatitis; Waist circumference

Year:  2013        PMID: 26202295     DOI: 10.1007/s12072-013-9477-5

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  33 in total

1.  Changes in the distribution of body mass index of adults and children in the US population.

Authors:  K M Flegal; R P Troiano
Journal:  Int J Obes Relat Metab Disord       Date:  2000-07

2.  Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression.

Authors:  Margareta Jernås; Jenny Palming; Kajsa Sjöholm; Eva Jennische; Per-Arne Svensson; Britt G Gabrielsson; Max Levin; Anders Sjögren; Mats Rudemo; Theodore C Lystig; Björn Carlsson; Lena M S Carlsson; Malin Lönn
Journal:  FASEB J       Date:  2006-06-05       Impact factor: 5.191

3.  The five-level model: a new approach to organizing body-composition research.

Authors:  Z M Wang; R N Pierson; S B Heymsfield
Journal:  Am J Clin Nutr       Date:  1992-07       Impact factor: 7.045

4.  Selection of measures in epidemiologic studies of the consequences of obesity.

Authors:  J Stevens; J E McClain; K P Truesdale
Journal:  Int J Obes (Lond)       Date:  2008-08       Impact factor: 5.095

Review 5.  The gut microbiota-a clinical perspective on lessons learned.

Authors:  Fergus Shanahan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-14       Impact factor: 46.802

6.  The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies.

Authors:  R P Troiano; E A Frongillo; J Sobal; D A Levitsky
Journal:  Int J Obes Relat Metab Disord       Date:  1996-01

7.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

8.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Stephen S Lim; Theo Vos; Abraham D Flaxman; Goodarz Danaei; Kenji Shibuya; Heather Adair-Rohani; Markus Amann; H Ross Anderson; Kathryn G Andrews; Martin Aryee; Charles Atkinson; Loraine J Bacchus; Adil N Bahalim; Kalpana Balakrishnan; John Balmes; Suzanne Barker-Collo; Amanda Baxter; Michelle L Bell; Jed D Blore; Fiona Blyth; Carissa Bonner; Guilherme Borges; Rupert Bourne; Michel Boussinesq; Michael Brauer; Peter Brooks; Nigel G Bruce; Bert Brunekreef; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Fiona Bull; Richard T Burnett; Tim E Byers; Bianca Calabria; Jonathan Carapetis; Emily Carnahan; Zoe Chafe; Fiona Charlson; Honglei Chen; Jian Shen Chen; Andrew Tai-Ann Cheng; Jennifer Christine Child; Aaron Cohen; K Ellicott Colson; Benjamin C Cowie; Sarah Darby; Susan Darling; Adrian Davis; Louisa Degenhardt; Frank Dentener; Don C Des Jarlais; Karen Devries; Mukesh Dherani; Eric L Ding; E Ray Dorsey; Tim Driscoll; Karen Edmond; Suad Eltahir Ali; Rebecca E Engell; Patricia J Erwin; Saman Fahimi; Gail Falder; Farshad Farzadfar; Alize Ferrari; Mariel M Finucane; Seth Flaxman; Francis Gerry R Fowkes; Greg Freedman; Michael K Freeman; Emmanuela Gakidou; Santu Ghosh; Edward Giovannucci; Gerhard Gmel; Kathryn Graham; Rebecca Grainger; Bridget Grant; David Gunnell; Hialy R Gutierrez; Wayne Hall; Hans W Hoek; Anthony Hogan; H Dean Hosgood; Damian Hoy; Howard Hu; Bryan J Hubbell; Sally J Hutchings; Sydney E Ibeanusi; Gemma L Jacklyn; Rashmi Jasrasaria; Jost B Jonas; Haidong Kan; John A Kanis; Nicholas Kassebaum; Norito Kawakami; Young-Ho Khang; Shahab Khatibzadeh; Jon-Paul Khoo; Cindy Kok; Francine Laden; Ratilal Lalloo; Qing Lan; Tim Lathlean; Janet L Leasher; James Leigh; Yang Li; John Kent Lin; Steven E Lipshultz; Stephanie London; Rafael Lozano; Yuan Lu; Joelle Mak; Reza Malekzadeh; Leslie Mallinger; Wagner Marcenes; Lyn March; Robin Marks; Randall Martin; Paul McGale; John McGrath; Sumi Mehta; George A Mensah; Tony R Merriman; Renata Micha; Catherine Michaud; Vinod Mishra; Khayriyyah Mohd Hanafiah; Ali A Mokdad; Lidia Morawska; Dariush Mozaffarian; Tasha Murphy; Mohsen Naghavi; Bruce Neal; Paul K Nelson; Joan Miquel Nolla; Rosana Norman; Casey Olives; Saad B Omer; Jessica Orchard; Richard Osborne; Bart Ostro; Andrew Page; Kiran D Pandey; Charles D H Parry; Erin Passmore; Jayadeep Patra; Neil Pearce; Pamela M Pelizzari; Max Petzold; Michael R Phillips; Dan Pope; C Arden Pope; John Powles; Mayuree Rao; Homie Razavi; Eva A Rehfuess; Jürgen T Rehm; Beate Ritz; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Jose A Rodriguez-Portales; Isabelle Romieu; Robin Room; Lisa C Rosenfeld; Ananya Roy; Lesley Rushton; Joshua A Salomon; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; Amir Sapkota; Soraya Seedat; Peilin Shi; Kevin Shield; Rupak Shivakoti; Gitanjali M Singh; David A Sleet; Emma Smith; Kirk R Smith; Nicolas J C Stapelberg; Kyle Steenland; Heidi Stöckl; Lars Jacob Stovner; Kurt Straif; Lahn Straney; George D Thurston; Jimmy H Tran; Rita Van Dingenen; Aaron van Donkelaar; J Lennert Veerman; Lakshmi Vijayakumar; Robert Weintraub; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Warwick Williams; Nicholas Wilson; Anthony D Woolf; Paul Yip; Jan M Zielinski; Alan D Lopez; Christopher J L Murray; Majid Ezzati; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

9.  The "metabolically-obese," normal-weight individual.

Authors:  N B Ruderman; S H Schneider; P Berchtold
Journal:  Am J Clin Nutr       Date:  1981-08       Impact factor: 7.045

10.  Insulin resistance and body fat distribution in South Asian men compared to Caucasian men.

Authors:  Manisha Chandalia; Ping Lin; Thanalakshmi Seenivasan; Edward H Livingston; Peter G Snell; Scott M Grundy; Nicola Abate
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

View more
  14 in total

1.  Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.

Authors:  Ren-Nan Feng; Shan-Shan Du; Cheng Wang; Yan-Chuan Li; Li-Yan Liu; Fu-Chuan Guo; Chang-Hao Sun
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

2.  Lean Fatty Liver Disease: Through Thick and Thin.

Authors:  Madhumita Premkumar; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-06-18

3.  Lean NAFLD: An Underrecognized Outlier.

Authors:  Julia Wattacheril; Arun J Sanyal
Journal:  Curr Hepatol Rep       Date:  2016-04-14

4.  Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.

Authors:  Alexandra Feldman; Sebastian K Eder; Thomas K Felder; Lyudmyla Kedenko; Bernhard Paulweber; Andreas Stadlmayr; Ursula Huber-Schönauer; David Niederseer; Felix Stickel; Simon Auer; Elisabeth Haschke-Becher; Wolfgang Patsch; Christian Datz; Elmar Aigner
Journal:  Am J Gastroenterol       Date:  2016-08-16       Impact factor: 10.864

5.  JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome.

Authors:  Kathryn D Tuttle; Katherine A Waugh; Paula Araya; Ross Minter; David J Orlicky; Michael Ludwig; Zdenek Andrysik; Matthew A Burchill; Beth A J Tamburini; Colin Sempeck; Keith Smith; Ross Granrath; Dayna Tracy; Jessica Baxter; Joaquin M Espinosa; Kelly D Sullivan
Journal:  Cell Rep       Date:  2020-11-17       Impact factor: 9.423

Review 6.  What Are the Current Pharmacological Therapies for Nonalcoholic Fatty Liver Disease?

Authors:  Deepu David; Chundamannil E Eapen
Journal:  J Clin Exp Hepatol       Date:  2020-09-03

7.  Lean Metabolic Syndrome: A Concept or a Reality?

Authors:  Pradip Mukhopadhyay; Sujoy Ghosh; Kingshuk Bhattacharjee; Kaushik Pandit; Partha Sarathi Mukherjee; Subhankar Chowdhury
Journal:  Indian J Endocrinol Metab       Date:  2018 May-Jun

Review 8.  Pathology of non-alcoholic fatty liver disease.

Authors:  Ivana Cataldo; Samantha Sarcognato; Diana Sacchi; Matilde Cacciatore; Francesca Baciorri; Alessandra Mangia; Nora Cazzagon; Maria Guido
Journal:  Pathologica       Date:  2021-06

9.  Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis.

Authors:  Atsuko Nakatsuka; Makoto Matsuyama; Satoshi Yamaguchi; Akihiro Katayama; Jun Eguchi; Kazutoshi Murakami; Sanae Teshigawara; Daisuke Ogawa; Nozomu Wada; Tetsuya Yasunaka; Fusao Ikeda; Akinobu Takaki; Eijiro Watanabe; Jun Wada
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

Review 10.  Recent research trends and updates on nonalcoholic fatty liver disease.

Authors:  Jeong-Ju Yoo; Won Kim; Moon Young Kim; Dae Won Jun; Sang Gyune Kim; Jong-Eun Yeon; Jin Woo Lee; Yong Kyun Cho; Sang Hoon Park; Joo Hyun Sohn
Journal:  Clin Mol Hepatol       Date:  2018-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.